Health & Healthcare

The data we presented at ECCMID 2022 is part of Gilead’s mission to advance access to effective therapies.

An outside expert eye can be tremendously valuable, especially when the stakes are high. It’s fair to say that where construction safety is concerned, the stakes are high. Working on construction sites is inherently dangerous.

Illumina’s advances in genetic sequencing are reshaping medicine. Genetic sequencing has now allowed cancer patients to find treatment options specific to their tumors, doctors to anticipate adverse drug reactions and personalize medicine, public health agencies around the world to track and detect new COVID variants, and patients with rare diseases to more easily identify and treat their illnesses.

Quest honors the dedication of all lab professionals providing essential insights that are vital to healthcare decisions.

Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, announced an agreement with Germany's Hannover Medical School (Medizinische Hochschule Hannover (MHH)) to implement the use of whole-genome sequencing (WGS) in critically ill children suspected of having a genetic or rare disease.

Two years into the pandemic that has killed millions and shaken the global economy, the world still lacks a unified effort to detect and fight future outbreaks using genetic tools, said Illumina Inc. Chief Executive Officer Francis deSouza.

A new study from the National Institute on Alcohol Abuse and Alcoholism shows alcohol-related deaths increased by 25% in 2020 and remained elevated in 2021.

Minority Health Month fact: Lesbian, gay, bisexual, and transgender adults are more likely to experience a mental health condition than cisgender, heterosexual adults.

When a new “rash” appears on the skin, many people may not associate it with psoriasis.